Cancer Control

 

To reduce cancer risk, incidence, morbidity, and mortality and enhance quality of life in cancer survivors through an orderly sequence from research on interventions and their impact in defined populations to the broad, systematic application of the research results through dissemination and diffusion strategies. Primary emphasis is on the inclusion of cancer prevention and control intervention(s) in any proposed study. Cancer Prevention and Cancer Control research studies are classified into one of five phases: (1) Hypothesis development; (2) methods development and testing; (3) controlled intervention trials to establish cause-and-effect relationships; (4) research in defined populations; and (5) demonstration and implementation studies. Primary interests are in research on cancer control interventions in Phases 2 through 5, and on cancer prevention research in all phases. Cancer Prevention and Control programs include those in the following areas: (1) cancer epidemiology; (2) cancer communications; (3) nutrition, diet, and physical activity; (4) screening and early detection in health care delivery; (5) biobehavioral mechanisms; (6) tobacco control; (7) health disparities research; (8) supportive care and survivorship; (9) health services and outcomes research; and (10) surveillance research. Cancer Control uses Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs to engage domestic small business concerns in federal research and development that has potential for commercialization. The goals of the SBIR & STTR Programs are to stimulate technological innovation, increase private-sector commercialization of federal research and development, increase small business participation in federally funded research and development, and foster participation by socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. The STTR Program requires the small business concern to formally collaborate with a research institution in Phase I and Phase II of the program.

General information about this opportunity
Last Known Status
Active
Program Number
93.399
Federal Agency/Office
National Institutes of Health, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Fiscal Year 2016 It is estimated that 0 awards will be made in FY2016 It is estimated that 0 awards were made in FY2016.
Fiscal Year 2017 It is estimated that 0 awards will be made in FY2017.
Fiscal Year 2018 0 awards were made in FY2018.
Fiscal Year 2019 0 awards were made in FY2019.
Fiscal Year 2020 Actual awards made in FY2020 was 0.
Fiscal Year 2021 It is estimated that 0 awards will be made in FY2021
Fiscal Year 2022 0 awards were made in FY2022
Fiscal Year 2023 It is estimated that 0 awards will be made in FY2023
Fiscal Year 2024 It is estimated that 0 awards will be made in FY2024
Authorization
Public Health Service Act, Sections 301, 410 and 412, Public Law 78-410, as amended, Public Law 99-500, Public Law 100-607, 42 U.S.C. 241, 42 U.S.C. 285 - 285a-1; Small Business Research and Development Enhancement Act of 1992, Public Law 102-564.
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
The awardee will be a university, college, hospital, public agency, nonprofit research institution or for-profit organization that submits an application and receives a grant or cooperative agreement for support of research by a named principal investigator. SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed, and have no more than 500 employees). Primary employment (more than one- half time) of the principal investigator must be with the small business at the time of award and for the duration of the project period. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit, technical merit, and program relevance by a scientific review group and a national advisory council. STTR grants can be awarded only to domestic small business concern (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. The Principal Investigator may be primarily employed by either the small business concern or the collaborating research institution at the time of award and for the duration of the project period. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit, technical merit and program relevance by a scientific review group and a national advisory council.
Beneficiary Eligibility
University, college, hospital, public agency, nonprofit research institutions or for-profit organizations will benefit.
Credentials/Documentation
For-profit organizations' costs are determined in accordance with 48 CFR, Subpart 31.2 of the Federal Acquisition Regulations. For other grantees, costs will be determined in accordance with HHS Regulations 45 CFR, Part 75. For SBIR and STTR grants, the applicant organization (small business concern) must present in a research plan an idea that has potential for commercialization and furnish evidence that scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. Grant form SF424(R&R) (version as specified in the FOA) is used to apply for SBIR Phase I and Phase II, and STTR Phase I and Phase II.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Depending on the grant mechanism, either form PHS-398 (Rev. March 2016) or form SF424(R&R) (Version as specified in the FOA) is the standard application form. Both forms can be obtained online at http://grants.nih.gov/grants/forms.htm. The standard application forms, as furnished by DHHS. SBIR and STTR Grant Solicitations and SBIR Contract Solicitations may be obtained electronically through the NIH Small Business Funding Opportunities home page at https://sbir.nih.gov/funding. The Solicitations include submission procedures, review considerations, and grant application or contract proposal forms. All competing SBIR and STTR grant applications should be submitted electronically to the NIH via Grants.gov (http://www.grants.gov/).
Award Procedure
Grants and cooperative agreements are funded based on scientific merit, program relevance, and program balance and are made annually. Initial award provides funds for first budget period (usually 12 months) and Notice of Grant Award (Form PHS 1533) indicates support recommended for remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
Regular Grants: Approximately 10 months. SBIR/STTR: About 7-l/2 months.
Appeals
A principal investigator (P.I.) may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available online through the NIH home page at https://grants.nih.gov/grants/peer-review.htm
Renewals
Applications submitted for renewal are reviewed and selected for funding on a competitive basis.
How are proposals selected?
The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives.
How may assistance be used?
Grants and cooperative agreements may be made to eligible institutions for the support of cancer research projects. The grants and cooperative agreements may be used for personnel, consultant costs, equipment, supplies, travel, patient costs, animals, alterations and renovations, miscellaneous items, and indirect costs. Restrictions are imposed against the use of funds for entertainment, foreign travel (unless specifically authorized), office equipment, and other items not normally necessary for the effective prosecution of such research. SBIR Phase I grants (of approximately 6-months' duration) are to establish the technical merit, feasibility and commercial potential of a proposed research effort and to determine the quality of performance of the awardee. Phase II grants are for the continuation of the research initiated in Phase I, and are likely to result in commercial products or processes. Only SBIR Phase I awardees are eligible to receive Phase II support. STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I, and the scientific and technical merit and commercial potential of the proposed Phase II project. Only STTR Phase I awardees are eligible to receive Phase II support. The NIH Fast-Track mechanism provides additional assistance to applicants by expediting the decision and award of funding for scientifically meritorious applications for projects that have a high potential for commercialization. The mechanism allows small businesses to submit applications for both Phase I and Phase II together for review as one application, with the aim of reducing or eliminating the funding gap between Phase I and Phase II.
What are the requirements after being awarded this opportunity?
Reporting
Not applicable.
Auditing
Grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Records
Expenditures and other financial records must be retained for 3 years from the day on which the grantee submits the last financial status report for the report period.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Grants and cooperative agreements average from 3 to 4 years, up to a maximum of 5 years. Renewals may be awarded for additional periods of up to 5 years based on competitive peer review. Funding is provided through Monthly Demand Payment System or an Electronic Transfer System. SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years. Method of awarding/releasing assistance: Letter.
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Catherine M. Battistone
9609 Medical Center Drive
Seventh Floor, West Tower, 7W532, MSC 9750

Rockville, MD 20850 US
battistc@mail.nih.gov
Phone: 240-276-6443
Fax: 240-276-7682
Website Address
http://cancercontrol.cancer.gov/
Financial Information
Account Identification
75-0849-0-1-550
Obligations
(Project Grants) FY 20$0.00; FY 21 est $0.00; FY 22 est $0.00; FY 19$0.00; FY 18$0.00; FY 17$0.00; FY 16$0.00; - Cancer Control Grants
Range and Average of Financial Assistance
Range 0 to 0 Average:: 0
Regulations, Guidelines and Literature
Grants: 42 CFR 52; 45 CFR 75 and NIH Grants Policy Statement
Examples of Funded Projects
Not applicable.

 


Related Federal Grants


Federal Grants Resources